Patents Assigned to Eyesiu Medicines B.V.
  • PEGylated lipid nanoparticle with bioactive lipophilic compound
    Patent number: 10945966
    Abstract: The invention relates to nanoparticles for the systemic or topical delivery of lipophilic diagnostic or therapeutic agents to a subject in need thereof. The nanoparticles of the invention comprise a water soluble polymer and at least one of a biocompatible lipid and a lipophilic agent. The invention further relates to ophthalmic treatment using the nanoparticles of the invention. In addition, the invention pertains to compositions and formulations comprising the nanoparticle of the invention. Such formulation may be an eye drop formulation.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: March 16, 2021
    Assignee: Eyesiu Medicines B.V.
    Inventors: Pieter Jaap Gaillard, Jacob Rip
  • PEGylated lipid nanoparticle with bioactive lipophilic compound
    Publication number: 20200163898
    Abstract: The invention relates to nanoparticles for the systemic or topical delivery of lipophilic diagnostic or therapeutic agents to a subject in need thereof. The nanoparticles of the invention comprise a water soluble polymer and at least one of a biocompatible lipid and a lipophilic agent. The invention further relates to ophthalmic treatment using the nanoparticles of the invention. In addition, the invention pertains to compositions and formulations comprising the nanoparticle of the invention. Such formulation may be an eye drop formulation.
    Type: Application
    Filed: November 13, 2019
    Publication date: May 28, 2020
    Applicant: Eyesiu Medicines B.V.
    Inventors: Pieter Jaap Gaillard, Jacob Rip
  • Pegylated lipid nanoparticle with bioactive lipophilic compound
    Patent number: 10525012
    Abstract: The invention relates to nanoparticles for the systemic or topical delivery of lipophilic diagnostic or therapeutic agents to a subject in need thereof. The nanoparticles of the invention comprise a water soluble polymer and at least one of a biocompatible lipid and a lipophilic agent. The invention further relates to ophthalmic treatment using the nanoparticles of the invention. In addition, the invention pertains to compositions and formulations comprising the nanoparticle of the invention. Such formulation may be an eye drop formulation.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: January 7, 2020
    Assignee: Eyesiu Medicines B.V.
    Inventors: Pieter Jaap Gaillard, Jacob Rip
  • PEGYLATED LIPID NANOPARTICLE WITH BIOACTIVE LIPOPHILIC COMPOUND
    Publication number: 20180235896
    Abstract: The invention relates to nanoparticles for the systemic or topical delivery of lipophilic diagnostic or therapeutic agents to a subject in need thereof. The nanoparticles of the invention comprise a water soluble polymer and at least one of a biocompatible lipid and a lipophilic agent. The invention further relates to ophthalmic treatment using the nanoparticles of the invention. In addition, the invention pertains to compositions and formulations comprising the nanoparticle of the invention. Such formulation may be an eye drop formulation.
    Type: Application
    Filed: August 11, 2016
    Publication date: August 23, 2018
    Applicant: Eyesiu Medicines B.V.
    Inventors: Pieter Jaap Gaillard, Jacob Rip